National and Kapodistrian University of Athens
Μελέτη του παράγοντα ανάπτυξης ινοβλαστών FGF21 και της ινσουλίνης στο αμνιακό υγρό δευτέρου τριμήνου εμβρύων με υπολειπόμενη ανάπτυξη
Abstract
dc:descriptionIntroduction: The fetoplacental unit through metabolic and endocrinological actions is the main regulator of fetal growth mainly during the second half of pregnancy. The amniotic fluid during the second trimester, due to its’ similar composition to fetal plasma, offers an accurate image of metabolic pathways that are active in fetuses with normal as well as abnormal growth patterns. Fetal growth restriction (estimated fetal weight below 10th centile for age), is characterized by metabolic and cardiovascular changes due to placental insufficiency, ischemia and hypoxia. Macrosomia (estimated fetal weight above 90th centile for age), is characterized by fetal hyperglycemia due to maternal hyperglycemia. Various factors have been studied regarding their potential role in fetal growth. Fibroblast growth factor 21 (FGF21) increases during hypoglycemia and acts mainly by increasing insulin sensitivity in adipose tissue. Insulin increases during hyperglycemia and acts mainly by anabolic actions. Purpose: Detection, quantification and association of FGF21 and insulin in amniotic fluid of second trimester fetuses with fetal growth during the end of the second trimester and 3rd trimester. Material: Samples of amniotic fluid from amniocentesis of 80 pregnancies during the second trimester (15-22 weeks) in the 2nd Obstetrics and Gynaecology Department at Aretaieio Hospital in Athens. Methods: Samples were obtained via amniocentesis, stored in -80 degrees until quantification, which was performed by immunoenzymatic analysis ELISA. Statistical analysis was performed by using the SPSS statistical package and the level of statistical significance was p<0.05. Results: The 80 samples were divided in 31 growth restricted, 18 large for gestational age and 31 appropriate for gestational age fetuses. They were compared in relation to maternal characteristics, fetal characteristics and birth weight. There was no statistically significant difference regarding maternal weight, maternal height, deliveries, smoking and gestational age between the three groups (p>0.05). There was statistical significant difference between maternal age (p=0.01), sex (p=0.02) and birth weight (p=0.01) between the three groups. FGF21 is increased in the growth restriction group compared to appropriate for gestational age (p=0.03) and large for gestational age (p=0.039). Insulin is decreased in the growth restriction group in relation to appropriate for gestational age and increased in relation to large for gestational age but without statistically significant difference. Discussion: The pathophysiological mechanisms involved in fetal growth are not clarified despite the identification of multiple risk factors. The possible association of the factors under study, with fetal growth abnormalities may assist in understanding these pathophysiological mechanisms. FGF21 which is significantly increased in growth restricted fetuses compared to other groups, is possibly associated with compensatory mechanisms of increased bioavailability and protective antistress qualities. Insulin is not statistically different between the three groups, possibly due to the fact that its’ levels were determined during the 2nd trimester while its’ action is more prominent during the 3rd trimester. The limitations of the study involve the small size per group, factors determination during the 2nd trimester and possible presence of additional affecting factors. Conclusions: Determination of FGF21 levels in the amniotic fluid may be used as a prognostic factor of growth abnormalities, and especially growth restriction. Larger studies are required to confirm the above findings but also study of other factors that may affect FGF21 and insulin. Early identification of pathophysiological pathways involved in growth abnormalities, may lead to implementation of interventions to decrease neonatal morbidity and mortality.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Argyridis, Savvas
- Αργυρίδης, Σάββας
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/54748